top of page
Wellumio Latest Updates
Market Insight
What the Boston Scientific–Penumbra acquisition signals, and why it matters for Wellumio Boston Scientific’s announced ~$14.5 billion acquisition of Penumbra marks one of the most significant medtech transactions in recent years. While often framed as a return to neurovascular intervention, the deeper signal is more consequential: time-critical acute care has become strategic infrastructure. For companies building upstream of intervention, the implications are material. From
Ruth Consuelo
Jan 263 min read
Wellumio and MEYTEC Sign MoU to Pioneer Next-Generation Stroke Imaging and Telemedicine Integration
WERNEUCHEN, GERMANY & MELBOURNE, AUSTRALIA MEYTEC, a leader in telemedicine and mobile emergency care technologies, and Wellumio, an...
Ruth Consuelo
May 20, 20252 min read
bottom of page